LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.81 | 84.90 | 1629 | 1769 | 0.9206 | 0.9626 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.51 | 84.90 | 1 | 1923 | 0.0005 | -0.6272 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.51 | 84.90 | 271 | 1923 | 0.1409 | 0.2941 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.51 | 84.90 | 54 | 1923 | 0.0281 | -0.0956 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.51 | 84.90 | 1735 | 1923 | 0.9022 | 0.9548 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.21 | 84.90 | 1 | 2091 | 0.0005 | -0.6174 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.21 | 84.90 | 327 | 2091 | 0.1564 | 0.3387 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.21 | 84.90 | 72 | 2091 | 0.0344 | -0.0350 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.21 | 84.90 | 1889 | 2091 | 0.9032 | 0.9564 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.92 | 84.90 | 1 | 2237 | 0.0004 | -0.6097 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.92 | 84.90 | 382 | 2237 | 0.1707 | 0.3752 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.92 | 84.90 | 93 | 2237 | 0.0416 | 0.0195 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.92 | 84.90 | 1997 | 2237 | 0.8924 | 0.9524 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 31.62 | 84.90 | 1 | 2449 | 0.0004 | -0.5997 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 31.62 | 84.90 | 428 | 2449 | 0.1747 | 0.3958 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 31.62 | 84.90 | 109 | 2449 | 0.0445 | 0.0529 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 31.62 | 84.90 | 2197 | 2449 | 0.8968 | 0.9556 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 33.32 | 84.90 | 1 | 2722 | 0.0004 | -0.5884 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 33.32 | 84.90 | 525 | 2722 | 0.1928 | 0.4393 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 33.32 | 84.90 | 136 | 2722 | 0.0500 | 0.0988 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 33.32 | 84.90 | 2367 | 2722 | 0.8695 | 0.9449 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 35.03 | 84.90 | 2 | 2991 | 0.0007 | -0.5178 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 35.03 | 84.90 | 646 | 2991 | 0.2160 | 0.4842 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 35.03 | 84.90 | 172 | 2991 | 0.0575 | 0.1473 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 35.03 | 84.90 | 2515 | 2991 | 0.8408 | 0.9336 | MN20160318_Q02 | I20 |